Digital Solving problems in pathology data, with Nathan Buchbinder Jonah Comstock chats with Nathan Buchbinder, co-founder and chief product officer at Proscia.
Digital Will clinical trials be held in the metaverse? Five ways the... The pronounced success of increased tech adoption in accelerating and streamlining clinical trials over the past few years has opened the floodgates for a slew of new technology and tactics
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
